羊种布鲁氏菌Rev1Δwzm:胎盘致病性研究与妊娠母羊安全性
为评估羊种布鲁氏菌Rev1Δwzm的胎盘致病性,研究在滋养层细胞、妊娠小鼠及66只不同妊娠期接种的母羊中与16MΔwzm和羊种布鲁氏菌比较。Rev1Δwzm在母羊中安全且有免疫原性,仅标准RBT出现短暂血清学干扰而CFT S-LPS试验无干扰,结膜接种可减少该反应,作者认为其是妊娠母羊有前景的候选疫苗且有效性需进一步研究。
要点
- 两种wzm突变体在Bewo滋养层细胞中触发的细胞毒性、促凋亡和促炎信号及凋亡基因相对表达均降低。
- 小鼠中两种wzm突变体均产生感染但迅速从胎盘清除,仅Rev1Δwzm诱导促凋亡和促炎基因低相对表达。
- 66只接种母羊中Rev1Δwzm安全且有免疫原性,标准RBT短暂血清学干扰而CFT S-LPS试验无干扰,结膜接种可减少该反应。
核心结论
- 作者认为羊种布鲁氏菌Rev1Δwzm是用于妊娠母羊的有前景候选疫苗,其对羊种布鲁氏菌和羊种布鲁氏菌感染的有效性需进一步研究。
研究设计与样本
- 研究在滋养层细胞、妊娠小鼠及不同妊娠期接种的66只母羊中评估Rev1Δwzm,并与源自强毒羊种布鲁氏菌的16MΔwzm及天然粗糙羊病原体羊种布鲁氏菌比较。
主要发现
- 两种wzm突变体在Bewo滋养层细胞中触发的细胞毒性、促凋亡和促炎信号及凋亡基因相对表达均降低。
- 小鼠中两种wzm突变体均产生感染但迅速从胎盘清除,仅Rev1Δwzm诱导促凋亡和促炎基因低相对表达。
- 66只接种母羊中Rev1Δwzm安全且有免疫原性,标准RBT出现短暂血清学干扰而CFT S-LPS试验无干扰,结膜接种可减少该血清学反应。
局限性
- 原文结论指出Rev1Δwzm对羊种布鲁氏菌和羊种布鲁氏菌感染的有效性需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
One of the main causes of human brucellosis is Brucella melitensis infecting small ruminants. To date, Rev1 is the only vaccine successfully used to control ovine and caprine brucellosis. However, it is pathogenic for pregnant animals, resulting in abortions and vaginal and milk shedding, as well as being infectious for humans. Therefore, there is an urgent need to develop an effective vaccine that is safer than Rev1. In efforts to further attenuate Rev1, we recently used wzm inactivation to generate a rough mutant (Rev1Δwzm) that retains a complete antigenic O-polysaccharide in the bacterial cytoplasm. The aim of the present study was to evaluate the placental pathogenicity of Rev1Δwzm in trophoblastic cells, throughout pregnancy in mice, and in ewes inoculated in different trimesters of pregnancy. This mutant was evaluated in comparison with the homologous 16MΔwzm derived from a virulent strain of B. melitensis and the naturally rough sheep pathogen B. ovis. Our results show that both wzm mutants triggered reduced cytotoxic, pro-apoptotic, and pro-inflammatory signaling in Bewo trophoblasts, as well as reduced relative expression of apoptosis genes. In mice, both wzm mutants produced infection but were rapidly cleared from the placenta, in which only Rev1Δwzm induced a low relative expression of pro-apoptotic and pro-inflammatory genes. In the 66 inoculated ewes, Rev1Δwzm was safe and immunogenic, displaying a transient serological interference in standard RBT but not CFT S-LPS tests; this serological response was minimized by conjunctival administration. In conclusion, these results support that B. melitensis Rev1Δwzm is a promising vaccine candidate for use in pregnant ewes and its efficacy against B. melitensis and B. ovis infections in sheep warrants further study.
引用
- Poveda-Urkixo I, Mena-Bueno S, Ramírez GA, et al. Brucella melitensis Rev1Δwzm: Placental pathogenesis studies and safety in pregnant ewes. Vaccine. 2024. PMID: 38755066. doi:10.1016/j.vaccine.2024.04.085
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。